Kevin M. Krause

Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant <i>Staphylococcus aureus</i>

Deborah L. Higgins, Ray Chang, Dmitri Debabov et al. · Antimicrobial Agents and Chemotherapy · 2005 · 426 citations · Full text

Microbial Pathogens, Antibacterial Activity, Antimicrobial Chemotherapy +22

Once-Daily Plazomicin for Complicated Urinary Tract Infections

Florian Wagenlehner, Daniel Cloutier, Allison Komirenko et al. · New England Journal of Medicine · 2019 · 205 citations

Urology, Gram-negative Uropathogens, Antibiotics +12

Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups

Mariana Castanheira, Sarah E. Farrell, Kevin M. Krause et al. · Antimicrobial Agents and Chemotherapy · 2013 · 177 citations · Full text

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 163 citations · Full text

Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes

Georgina Cox, Linda Ejim, P.J. Stogios et al. · ACS Infectious Diseases · 2018 · 138 citations · Full text